A lawsuit for certain investors in ChemoCentryx, Inc. (NASDAQ: CCXI) is pending and NASDAQ: CCXI stockholders should contact the Shareholders Foundation.

San Diego, CA -- (SBWire) -- 04/26/2022 --An update was announced in the lawsuit that is pending for certain investors in in shares of ChemoCentryx, Inc. (NASDAQ: CCXI) against ChemoCentryx, Inc.over alleged Securities Laws Violations..

Investors who are current long term investors in ChemoCentryx, Inc. (NASDAQ: CCXI) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

On May 5, 2021, a lawsuit was filed against ChemoCentryx, Inc over alleged securities laws violations. The plaintiff alleged that between November 26, 2019 and May 3, 2021, the defendants made false and/or misleading statements and/or failed to disclose that the study design of the Phase III ADVOCATE trial presented issues about the interpretability of the trial data to define a clinically meaningful benefit of avacopan and its role in the management of ANCA-associated vasculitis, that the data from the Phase III ADVOCATE trial raised serious safety concerns for avacopan, that these issues presented a substantial concern regarding the viability of ChemoCentryx's NDA for avacopan for the treatment of ANCA-associated vasculitis, and that as a result of the foregoing, Defendants' public statements were materially false and misleading at all relevant times.

On March 28, 2022, an amended consolidated complaint was filed.

Those who purchased shares of ChemoCentryx, Inc. (NASDAQ: CCXI) have certain options and should contact the Shareholders Foundation.

Contact:
Shareholders Foundation, Inc.
Christopher Clausen
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com

About The Shareholders Foundation
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.